Linus Biotechnology Inc. Receives FDA Breakthrough Device Designation forStrandDx™-ASD Exposome Sequencing Diagnostic
/PRNewswire/ -- Linus Biotechnology Inc., a leader in precision exposome sequencing, today announced that the U.S. Food and Drug Administration Center for...
Source: prnewswire.com